Recent news

20 Apr 2017

Finalization of shareholder change

Partners Group and PSP Investments have finalized the acquisition of Cerba HealthCare, a leading European operator of clinical pathology laboratories, from PAI Partners.

PR_Closing_Cerba_Healthcare_EN.pdf
30 Mar 2017

Cerberus Nightingale 1

Notice of redemption

Cerberus_Nightingale_Notice_of_Redemption.pdf
21 Mar 2017

Cerba HealthCare Press Release

Paris, France, March 21, 2017. Cerba Healthcare S.A.S. and its affiliates (the “Cerba Group”) announced today that NewCo Sab MidCo S.A.S...

Cerba-HealthCare-Press-Release.pdf
20 Mar 2017

Cerba HealthCare S.A.S

Conditional notice of redemption.

Cerba_HealthCare_SAS.pdf
20 Mar 2017

Cerba HealthCare - Launch Press Release

Cerba HealthCare - Launch Press Release

Cerba_HealthCare_Launch__Press_Release.pdf
08 Mar 2017

Licensing agreement between Cerba and IntegraGen for the commercialization...

Licensing agreement between Cerba and IntegraGen for the commercialization of miR-31-3p tumor expression test in cancerology.

Cerba_IntegraGen_Press_Release_EN.pdf
23 Feb 2017

Cerba HealthCare S.A.S announces preliminary financial results ...

Cerba HealthCare S.A.S announces preliminary financial results for year end 2016 and expected redemption of existing notes.

Press_Release_2016.pdf
22 Feb 2017

The ambassador of Russia visits Laboratoire Ketterthill

Web site 

Visite_ambassadeur.pdf
13 Feb 2017

iDTECT™ BLOOD test for precision diagnosis of infectious diseases

Diagnosis of infectious diseasesthe iDTECT™ BLOOD test available for clinical use in the precision Laboratoire CERBA and PATHOQUEST announce partnership making.

Cerba_PATHOQUEST_PR_EN.pdf
07 Feb 2017

Cerba HealthCare strengthens its positions in Europe

Cerba HealthCare is announcing the acquisition of DELTAMEDICA, a medical group located in Northern Italy in the Milan region.

CERBA HEALTHCARE_DELTAMEDICA_EN.pdf